Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
Cover Image

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2014 in Pharmaceuticals

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for December 2014 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in December 2014. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

  • Analysis of the market trends for the pharmaceutical industry in the global arena.
  • Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
  • Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
  • Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
  • Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
  • Analysis of partnership and licensing deals based on clinical stage of development of products.
  • Summary of the pharmaceutical deals globally in the six months.
  • Information on the top deals happened in the pharmaceutical industry.
  • Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
  • League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

  • Enhance your decision making capability in a more rapid and time sensitive manner.
  • Find out the major deal performing segments for investments in your industry.
  • Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
  • Identify companies that are aggressively looking to raise capital in the market
  • Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
  • Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
  • Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
  • Identify growth segments and opportunities in each region within the industry.
  • Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Pharmaceuticals & Healthcare, Global, Deal Summary 12

  • 2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2014 12
  • 2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2014 14
    • 2.2.1 Medtronic Raises USD17 Billion in Private Placement of Notes 14
    • 2.2.2 Merck Acquires Cubist Pharma for USD9.5 Billion 14
    • 2.2.3 Becton, Dickinson Raises USD6.2 Billion in Public Offering Notes 15
    • 2.2.4 Otsuka to Acquire Avanir Pharma for USD3.5 Billion 15
    • 2.2.5 Merck Raises USD1.8 Billion in Private Placement of Bonds 17
  • 2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2014 18
  • 2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2014 19

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20

  • 3.1 Pharmaceuticals & Healthcare, Global, M&A, November 2014 20
    • 3.1.1 Top M&A Deals in December 2014 21
    • 3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2014 - December 2014 22
  • 3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2014 23
    • 3.2.1 Top Equity Offering Deals in December 2014 24
    • 3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2014 - December 2014 25
  • 3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2014 27
    • 3.3.1 Top PE/VC Deals in December 2014 28
    • 3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2014 29
    • 3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2014 30
    • 3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2014-December 2014 32
    • 3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2014-December 2014 33

4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2014 34

  • 4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2014 34
  • 4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2014 - December 2014 36
  • 4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2014 37
    • 4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2014 38
  • 4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 39
  • 4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2014 - December 2014 41
  • 4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2014 - December 2014 42
  • 4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 44

5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2014 45

  • 5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2014 45
  • 5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2014 47
    • 5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2014 48
    • 5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2014 49
    • 5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2014 50
  • 5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2014 - December 2014 51
  • 5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2014 - December 2014 53
  • 5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2014 - December 2014 55
  • 5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2014 - December 2014 57

6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 59

  • 6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2014 59
    • 6.1.1 Oncology - Deals of the Month 60
  • 6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2014 63
    • 6.2.1 Central Nervous System - Deals of the Month 64
  • 6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2014 66
    • 6.3.1 Infectious Diseases - Deals of the Month 67
  • 6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2014 69
    • 6.4.1 Cardiovascular - Deals of the Month 70
  • 6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2014 72
    • 6.5.1 Immunology - Deal of the Month 73
  • 6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, December 2014 75
    • 6.6.1 Gastrointestinal - Deals of the Month 76
  • 6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, December 2014 78
    • 6.7.1 Metabolic Disorders - Deal of the Month 79

7 Deal Summary by Geography 81

  • 7.1 Pharmaceuticals & Healthcare, North America Deals, December 2014 81
    • 7.1.1 North America - Deals of the Month 83
  • 7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2014 86
    • 7.2.1 Europe - Deals of the Month 87
  • 7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2014 89
    • 7.3.1 Asia-Pacific - Deals of the Month 90
  • 7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2014 92
    • 7.4.1 Rest of the World - Deals of the Month 93

8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 95

  • 8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2014 - December 2014 95
  • 8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2014 - December 2014 97

9 Further Information 99

  • 9.1 Methodology 99
  • 9.2 About GlobalData 100
  • 9.3 Disclosure information 101
  • 9.4 Disclaimer 101

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 13
  • Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, November 2014 14
  • Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), December 2014 19
  • Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 21
  • Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, December 2014 21
  • Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2014 - December 2014 22
  • Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 24
  • Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, December 2014 24
  • Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 26
  • Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 28
  • Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, December 2014 28
  • Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, July 2014 - December 2014 29
  • Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), December 2014 31
  • Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 32
  • Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2014 - December 2014 33
  • Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 35
  • Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 36
  • Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 37
  • Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), December 2014 38
  • Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 40
  • Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2014 - December 2014 43
  • Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), July 2014 - December 2014 44
  • Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 46
  • Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 48
  • Table 25: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, December 2014 48
  • Table 26: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, December 2014 49
  • Table 27: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, December 2014 50
  • Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 52
  • Table 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), December 2014 54
  • Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2014 - December 2014 56
  • Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2014 58
  • Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 60
  • Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 64
  • Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 67
  • Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 70
  • Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 73
  • Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 76
  • Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 79
  • Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 82
  • Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 87
  • Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 90
  • Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 93
  • Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 96
  • Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 98

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 12
  • Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%),December 2014 18
  • Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), December 2014 19
  • Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 20
  • Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2014 - December 2014 22
  • Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 23
  • Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 25
  • Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 27
  • Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2014 - December 2014 29
  • Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), December 2014 30
  • Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), December 2014 31
  • Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 32
  • Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 34
  • Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 36
  • Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 37
  • Figure 16:Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 39
  • Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2014 - December 2014 41
  • Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2014 - December 2014 42
  • Figure 19:Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 44
  • Figure 20:Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 45
  • Figure 21:Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 47
  • Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 51
  • Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2014 - December 2014 53
  • Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, July 2014 - December 2014 55
  • Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), July 2014 - December 2014 56
  • Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), December 2014 57
  • Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 59
  • Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 63
  • Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 66
  • Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 69
  • Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 72
  • Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 75
  • Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 78
  • Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 81
  • Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 86
  • Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 89
  • Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 92
  • Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 95
  • Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), July 2014 - December 2014 97
Show More
Pricing
Back to Top